Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Arcutis Biotherapeutics Inc (ARQT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Arcutis's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.73 -0.20    -2.29%
23/04 - Closed. Currency in USD ( Disclaimer )
After Hours
8.81
+0.08
+0.92%
0:27:50 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,582,726
  • Bid/Ask: 8.74 / 8.81
  • Day's Range: 8.73 - 9.30
Arcutis 8.73 -0.20 -2.29%

ARQT Overview

 
"Arcutis Biotherapeutics Inc stock price live, this page displays NASDAQ ARQT stock exchange data. View the ARQT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arcutis Biotherapeutics Inc real time stock price chart below.

What Is the Arcutis Biotherapeutics Inc Stock Price Today?
The Arcutis Biotherapeutics Inc stock price today is 8.73.

What Is the Stock Symbol for Arcutis Biotherapeutics Inc?
The stock symbol for Arcutis Biotherapeutics Inc is ""ARQT.""

What Stock Exchange Does Arcutis Biotherapeutics Inc Trade On?
Arcutis Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.

Is Arcutis Biotherapeutics Inc a Good Stock to Buy?
Determining whether Arcutis Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARQT quote. (ISIN: US03969K1088)"
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close8.94
Day's Range8.73 - 9.3
Revenue59.61M
Open9.02
52 wk Range1.76 - 15.21
EPS - 3.78
Volume1,582,726
Market Cap1B
Dividend (Yield)N/A (N/A)
Average Volume (3m)4,525,728
P/E Ratio - 2.33
BetaN/A
1-Year Change - 34.26%
Shares Outstanding114,971,258
Next Earnings DateMay 01, 2024
What is your sentiment on Arcutis?
or
Market is currently closed. Voting is open during market hours.

Arcutis Biotherapeutics Inc News


Arcutis Biotherapeutics Inc Analysis


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Sell Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Bullish doji Star 15 1 Apr 23, 2024 21:30
Falling Three Methods 1D 3 Apr 18, 2024
Engulfing Bearish 1H 4 Apr 23, 2024 17:00
Three Black Crows 1W 5 Mar 17, 2024
Three Outside Down 5H 6 Apr 18, 2024 18:00

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Access Holdings 16.70 16.70 16.70 +0.65 +4.05% 617.11K  
  MTN Nigeria 201.60 201.60 201.60 0.00 0.00% 11.16K  
  Lafarge Africa 36.00 36.00 36.00 0.00 0.00% 27.44K  
  Guaranty Trust Holding 36.00 36.00 36.00 +0.25 +0.70% 50.37K  
  UBA 23.20 23.20 23.20 +0.20 +0.87% 149.04K  
  Fcmb 7.150 7.150 7.150 +0.650 +10.00% 28.97K 10:17:00  
  Transcorp 14.000 14.700 14.000 -0.900 -6.04% 1.65M 10:20:00  
  Zenith Bank 37.00 37.50 37.00 +1.00 +2.78% 1.66M 10:18:00  
  Nestle Nigeria 880.00 880.00 880.00 +60.00 +7.32% 0.52K  
  Vitafoam Nig 18.70 18.70 18.70 +1.55 +9.04% 32.43K 10:12:00  

Arcutis Biotherapeutics Inc Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

268

Equity Type

ORD

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARQT Comments

Write your thoughts about Arcutis Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email